(Q33918359)

30 July 2017

title

The impact of patient-perceived restricted access to anti-TNF therapy for rheumatoid arthritis: a qualitative study (English)

1 reference

30 July 2017

0 references

1 reference

1 reference

1

Tessa Sanderson

1 reference

30 July 2017

Michael Calnan

2

1 reference

30 July 2017

Marianne Morris

series ordinal

3

1 reference

30 July 2017

Pam Richards

series ordinal

4

1 reference

30 July 2017

Sarah Hewlett

series ordinal

5

1 reference

30 July 2017

publication date

1 September 2009

1 reference

30 July 2017

1 reference

30 July 2017

volume

7

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

194-209

1 reference

Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug.

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Switching tumor necrosis factor inhibitors: an opinion

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Adalimumab for treating rheumatoid arthritis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Patients' perceptions of treatment with anti-TNF therapy for rheumatoid arthritis: a qualitative study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Infliximab in active early rheumatoid arthritis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Etanercept for the treatment of rheumatoid arthritis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Infliximab for the treatment of rheumatoid arthritis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Thrombolytic treatment for elderly patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Empowering processes and outcomes of participation in online support groups for patients with breast cancer, arthritis, or fibromyalgia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Are anti-TNFalpha therapies too good? An audit of patients' compliance.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

UK consultant rheumatologists' access to biological agents and views on the BSR Biologics Register.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Nonresponse to tumor necrosis factor antagonists--is there any point in re-treatment?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Rheumatology outcomes: the patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Rheumatology outcomes: the patient's perspective

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Development of a disease activity score based on judgment in clinical practice by rheumatologists.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886965

Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability

29 October 2018

1 reference

12 December 2020

Treatment choices, preferences and decision-making by patients with rheumatoid arthritis

1 reference

12 December 2020

Measurement of patient outcome in arthritis

1 reference

12 December 2020

Age rationing for renal transplantation? The role of age in decisions regarding scarce life extending medical resources

1 reference

12 December 2020

An exploration of patients' experiences of anti-TNF therapy

1 reference

12 December 2020

Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes

1 reference

12 December 2020

Outcomes generated by patients with rheumatoid arthritis: how important are they?

1 reference

12 December 2020

Identifiers

DOI

10.1002/MSC.149

1 reference

30 July 2017

1 reference

30 July 2017

1 reference